Assessing Video Evidence to Understand Sudden Unexplained Death in Children: Orrin Devinsky, MD
January 19th 2024The director of NYU Langone’s Comprehensive Epilepsy Center discussed a recently published study that used videos to identify potential causes of sudden deaths in toddlers. [WATCH TIME: 4 minutes]
Raising Discussion on Gaps in SUDEP Knowledge in Epilepsy Care: Jude Luker, BA (Hons)
January 17th 2024The head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma discussed findings from a literature review presented at AES 2023 involving conversations about sudden unexpected death in epilepsy. [WATCH TIME: 4 minutes]
Management of Spasticity Post Stroke, From Stretching to Surgical Options: Harmony Sierens, MD
January 17th 2024The medical director of the Inpatient Rehabilitation Unit at Ascension Genesys Hospital explored the various interventions for managing spasticity after stroke, from stretching exercises to surgical procedures. [WATCH TIME: 3 minutes]
A Clinical Preview of 2024 for Movement Disorders: Kelly Papesh, DNP, APRN, FNP-BC
January 15th 2024The clinical director of Parkinson & Movement Disorder Alliance shared her thoughts on potential therapies to increase management care options for patients with Parkinson disease. [WATCH TIME: 5 minutes]
Patient-Centered Care to Address Symptoms in Migraine Treatment: Amaal Starling, MD, FAHS, FAAN
January 14th 2024The associate professor in the department of neurology at Mayo Clinic College of Medicine talked about the importance of adopting a patient-centered approach in migraine treatment and the often overlooked impact of brain fog in patients with migraine. [WATCH TIME: 4 minutes]
Long-Term Findings on Hyperbaric Oxygen Therapy for Long COVID Treatment: Amir Hadanny, MD, PhD
January 12th 2024The chief medical research officer and head of research at Aviv Clinics talked about the anticipation of long-term results on a randomized controlled trial assessing hyperbaric oxygen therapy, a treatment for long COVID. [WATCH TIME: 5 minutes]
Changing the Perception of Narcolepsy to Reduce Stigma: Mark I. Boulos, MD, MSc, FRCP, CSCN
January 11th 2024The associate professor, department of medicine, division of neurology, Institute of Medical Science, University of Toronto, discussed recent research that challenged the conventional definitions of sleep and how narcolepsy is often stigmatized. [WATCH TIME: 2 minutes]
Understanding and Managing Spasticity in Poststroke Rehabilitation: Harmony Sierens, MD
January 10th 2024The medical director of the Inpatient Rehabilitation Unit at Ascension Genesis Hospital talked about the management of poststroke spasticity and highlighted the importance of awareness, education, and early intervention. [WATCH TIME: 5 minutes]
Exploring Epstein Barr Virus Connection in Multiple Sclerosis Research: J. William Lindsey, MD
January 8th 2024The professor in the department of neurology with McGovern Medical School at UTHealth Houston talked about findings from a recent study that investigated T cell specificity in the spinal fluid of patients with multiple sclerosis. [WATCH TIME: 10 minutes]
Addressing the Unmet Needs of Managing MS Symptoms: Michael Y. Sy, MD, PhD
January 8th 2024The associate professor of clinical neurology at University of California, Irvine School of Medicine talked about addressing the critical unmet needs in disability progression among patients with multiple sclerosis. [WATCH TIME: 3 minutes]
Pathing the Next Steps in Alzheimer Disease Research: Heather Snyder, PhD
January 8th 2024The vice president of medical and scientific relations at the Alzheimer’s Association discussed where the organization’s efforts are currently invested and the ways to continue momentum in the Alzheimer disease field. [WATCH TIME: 5 minutes]
Neurologist’s Role in Addressing Healthcare Disparities: A. Gordon Smith, MD, FAAN
January 7th 2024The professor and chair of neurology at Virginia Commonwealth University discussed how neurologists are urged to take organized action and provide training on healthcare disparities, with a particular focus on race, ethnicity, and financial barriers to access. [WATCH TIME: 2 minutes]
The Complexity of Frontotemporal Dementia and Potential of COYA 301: Stanley H. Appel, MD
January 5th 2024The director of the Ann Kimball and John W. Johnson Center for Cellular Therapeutics at Houston Methodist Hospital discussed the clinical manifestations of frontotemporal dementia (FTD) and how Coya Therapeutics is moving toward precision medicine with their FTD candidate, COYA 301. [WATCH TIME: 4 minutes]
A Call for Urgent Action to Redefine Stroke Protocols: Stephan A. Mayer, MD, FCCM, FNCS
January 5th 2024The director of neurocritical care and emergency neurology services at Westchester Medical Center Health System talked about a recently published paper that highlighted the need to address the disparity in quality metrics for stroke care, especially for intracerebral hemorrhage. [WATCH TIME: 4 minutes]
Steps to Validate Stathmin-2 as an ALS-Specific Biomarker: Cathleen Lutz, PhD
January 4th 2024The vice president of the Rare Disease Translational Center at the Jackson Laboratory provided commentary on the next steps needed to further understand stathmin-2’s role as a potential disease-modifying biomarker. [WATCH TIME: 3 minutes]